• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center
 

SPOREs

Breast

Scientific Advances

Publications:

1. Wang Q, Weisberg E, Zhao JJ. The gene dosage of class Ia PI3K dictates the development of PTEN hamartoma tumor syndrome. Cell Cycle. 2013 Oct 15;12(23). [Epub ahead of print]


2. Hanker AB, Pfefferle AD, Balko JM, Kuba MG, Young CD, Sánchez V, Sutton CR, Cheng H, Perou CM, Zhao JJ*, Cook RS, Arteaga CL*. Mutant PIK3CA accelerates HER2-driven transgenic mammary tumors and induces resistance to combinations of anti-HER2 therapies. <http://www.ncbi.nlm.nih.gov/pubmed/23940356>  Proc Natl Acad Sci U S A. 2013 Aug 27;110(35):14372-7. doi: 10.1073/pnas.1303204110. PMID:23940356
*Co-corresponding author